Efficacy, Safety, and Tolerance of the Non-Ergoline Dopamine Agonist Pramipexole in the Treatment of Advanced Parkinson's Disease:A Double Blind, Placebo Controlled, Randomised, Multicentre Study
JNNP 66:436-441, Pinter,M.M.,et al, 1999
Electrical Stimulation of the Subthalamic Nucleus in Advanced Parkinson's Disease
NEJM 339:1105-1111, Limousin,P.,et al, 1998
A Prediction Model for Functional Recovery in Stroke
Stroke 28:550-556, Stineman,M.G.,et al, 1997
Herpes Simplex Encephalitis Treated with Acyclovir:Diagnosis and Long Term Outcome
JNNP 63:321-326, McGrath,N.,et al, 1997
Influence of Age on Stroke Outcome:Copenhagen Stroke Study
Stroke 25:808-813, Nakayama,H.,et al, 1994
Extent of Pontine Pyramidal Tract Wallerian Degeneration and Outcome after Supratentorial Hemorrhagic Stroke
Stroke 25:1207-1210, Fukui,K.,et al, 1994
The Frenchay Activities Index, Assessment of Functional Status in Stroke Patients
Stroke 24:1173-1177, Schuling,J.,et al, 1993
Evaluation of Long-Term Outcome and Safety After Hemodilution Therapy in Acute Ischemic Stroke
Stroke 23:657-662, Strand,T., 1992
Level of Function Predicts First Stroke in the Elderly
Stroke 23:1355-1357, Colantonio,A.,et al, 1992
Unilateral Transpl of Human Fetal Mesencephalic Tissue Into the Caudate Nucleus of Pts with Parkinson's
NEJM 327:1541-1548, Spencer,D.D.,et al, 1992
Survival of Implanted Fetal Dopamine Cells & Neuro Improvement 12 to 46 Months after Transpl for Parkinson's
NEJM 327:1549-1555, 15891992., Freed,C.R.,et al, 1992
A Critical Appraisal of Stroke Evaluation and RAting Scales
Stroke 22:1345-1352, Lyden,P.D.&Lau,G.T., 1991